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Introduction: Necrotizing fasciitis (NF) is a life-threatening illness, particularly when surgical
debridement is delayed. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score
was developed to identify patients at higher risk for NF. Despite limited information in this regard,
the LRINEC score is often used to “rule out” NF if negative. We describe the sensitivity of the
LRINEC score in emergency department (ED) patients for the diagnosis of NF.
Methods: We conducted a chart review of ED patients in whom coding of hospital discharge
diagnoses included NF. We employed standard methods to minimize bias. We used laboratory
data to calculate the LRINEC score, and confirmed the diagnosis of NF via explicit chart review.
We then calculated the sensitivity of a positive LRINEC score (standardly defined as six or greater)
in our cohort. We examined the role of patient characteristics in the performance of the LRINEC
score. Finally, we performed sensitivity analyses to estimate whether missing data for c-reactive
protein (CRP) results were likely to impact our results.
Results: Of 266 ED patients coded as having a discharge diagnosis of NF, we were able to confirm
the diagnosis, by chart review, in 167. We were able to calculate a LRINEC score in only 80
patients (due to absence of an initial CRP value); an LRINEC score of 6 or greater had a sensitivity
of 77%. Sensitivity analyses of missing data supported our finding of inadequate sensitivity to rule
out NF. In sub-analysis, NF patients with concurrent diabetes were more likely to be accurately
categorized by the LRINEC score.
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Introduction: Necrotizing fasciitis (NF) is a life-threatening illness, particularly when surgical 
debridement is delayed. The Laboratory Risk Indicator for Necrotizing Fasciitis (LRINEC) score was 
developed to identify patients at higher risk for NF. Despite limited information in this regard, the 
LRINEC score is often used to “rule out” NF if negative. We describe the sensitivity of the LRINEC 
score in emergency department (ED) patients for the diagnosis of NF.
Methods: We conducted a chart review of ED patients in whom coding of hospital discharge 
diagnoses included NF. We employed standard methods to minimize bias. We used laboratory data 
to calculate the LRINEC score, and confirmed the diagnosis of NF via explicit chart review. We then 
calculated the sensitivity of a positive LRINEC score (standardly defined as six or greater) in our 
cohort. We examined the role of patient characteristics in the performance of the LRINEC score. 
Finally, we performed sensitivity analyses to estimate whether missing data for c-reactive protein 
(CRP) results were likely to impact our results. 
Results: Of 266 ED patients coded as having a discharge diagnosis of NF, we were able to confirm 
the diagnosis, by chart review, in 167. We were able to calculate a LRINEC score in only 80 patients 
(due to absence of an initial CRP value); an LRINEC score of 6 or greater had a sensitivity of 77%. 
Sensitivity analyses of missing data supported our finding of inadequate sensitivity to rule out NF. In 
sub-analysis, NF patients with concurrent diabetes were more likely to be accurately categorized by 
the LRINEC score.
Conclusion: Used in isolation, the LRINEC score is not sufficiently sensitive to rule out NF in a 
general ED population. [West J Emerg Med. 2016;17(3):333–336.]
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Necrotizing fasciitis (NF) is a life-threatening infection 
with high mortality. Because NF can be misdiagnosed as 
a less lethal mimic, such as cellulitis and abscess, efforts 
have been made to identify clinical features that could help 
clinicians accurately diagnose NF and avoid delays to surgical 
debridement.1 Prior retrospective studies have shown certain 
laboratory values, particularly an extremely elevated leukocyte 
count and a low sodium concentration, are associated with 
NF.2 These abnormal values might help clinicians distinguish 
NF from less severe soft-tissue infections. The Laboratory 
Risk Indicator for Necrotizing Fasciitis (LRINEC) score was 
developed in a large cohort of admitted patients to identify 
patients at higher risk for NF.3 Patients are assigned a LRINEC 
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Figure. Count of cases at each Laboratory Risk Indicator for 
Necrotizing Fasciitis (LRINEC) score.
score based on serum sodium, glucose, creatinine, c-reactive 
protein (CRP), leukocyte count and hemoglobin. Scores range 
from 0 to 13; a score 6 or greater was associated with a high 
risk of NF, and a score of 8 or greater with a very high risk.
The LRINEC score can be easily misapplied, however. 
The score was not designed to exclude NF in patients 
with a low-risk score, and case reports and small studies 
externally validating the score failed to replicate the high 
sensitivity and negative predictive value reported in the 
initial paper.4-8 Additionally, the sensitivity of the score 
has not been addressed specifically among emergency 
department (ED) patients. 
We conducted this retrospective study to determine 
the sensitivity of the LRINEC score in ED patients with a 
confirmed diagnosis of NF and examine the role of patient 
factors in the score’s sensitivity. We also performed secondary 
analyses to estimate how missing laboratory values impacted 
our results.
METHODS
The study was approved by the institutional review board 
prior to initiation. 
The study cohort consisted of patients evaluated in the 
ED of Los Angeles County+University of Southern California 
Medical Center (LAC+USC) with NF. The LAC+USC 
ED is an urban, academic, tertiary care hospital. Patients 
were identified by search of all International Statistical 
Classification of Diseases and Related Health Problems, Ninth 
Revision (ICD-9) hospital discharge codes between April 
2003 and April 2013; charts of all patients coded as having NF 
(728.86) were then reviewed, and further categorized as either 
“confirmed” or “unconfirmed” (see below.) Patients who were 
not initially evaluated in the ED or who developed NF post-
operatively after admission were excluded.
Primary Study: Sensitivity of the LRINEC Score in ED 
Patients
Chart Abstraction Methods
We used standard abstraction methods to minimize bias.9 
All abstractors received training. Medical students blinded 
to the study hypothesis calculated the LRINEC score after 
two training sessions; the lead author also reviewed their first 
results to ensure reliability and accuracy, and a coding guide 
was made available to abstractors (Appendix 1). The lead 
author reviewed 10% of cases, and with a Kappa calculated 
for abstracted variables. 
Diagnosis Confirmation
The ICD-9 diagnosis of NF was confirmed if any of the 
following criteria were met: 1) NF was a diagnosis on the hospital 
discharge or death summary; 2) NF was confirmed at surgery, 
as documented by operative report; or 3) fascial necrosis was 
documented on an anatomic pathology specimen. Patients with 
ICD-9 coding of “NF” but in whom none of these criteria were 
met, were classified as “unconfirmed” and were excluded.
LRINEC Scores
During laboratory value review, abstractors were blinded 
to the final “confirmation” of NF in any individual case. 
Only the first value for each laboratory test was collected, 
eliminating conflicting data. Abstractors coded a result 
as “missing” if there was no result in the first 48 hours of 
the hospital course; this occurred only with CRP; all other 
laboratory tests were present for every patient. These cases 
were excluded as no score could be calculated.
Patient Characteristics
Patient age, gender and inpatient mortality were collected 
from administrative data. Past medical history was abstracted 
from medical history and final diagnoses on operative reports, 
discharge summaries and death notes.
Primary Study: Sensitivity of LRINEC score, and 
Association with Patient Factors
A LRINEC score was calculated for each patient (Figure), 
and the overall sensitivity of the score was calculated using 
STATA version13, with a binomial model for confidence 
intervals. We included only patients with complete data. We 
used chi-squared tests and t-tests to examine the sensitivity of 
the LRINEC score when stratifying by patient factors of age, 
gender, inpatient mortality and history of cirrhosis, intravenous 
drug use or diabetes, known risk factors for developing NF.
Secondary Study: Analysis of Missing Data 
All cases without laboratory results to calculate a 
LRINEC score were missing a CRP, so we performed 
sensitivity analyses to determine how this impacted our 
results. We calculated a LRINEC score for each patient 
with missing data based on the assumption that the missing 
CRP value “would have been” positive in 50%, 77% (the 
sensitivity of the LRINEC score found in our cohort), or 
100% of cases. Because of the large contribution of CRP 
to the LRINEC score, we assumed that if the CRP was 
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Age (mean, SD) 47.5 (1.4)
History of diabetes 49%
History IVDU 18%
History of cirrhosis 6%
LRINEC score positive 76%
LRINEC score negative 34%
Table. Characteristics of patients with confirmed necrotizing fasciitis.
IVDU, intravenous drug user; LRINEC, laboratory risk indicator for 
necrotizing fasciitis




A computerized records search identified 316 patients 
between April 2003 and April 2013 with ICD-9 discharge 
diagnosis of NF. We excluded 47 cases that were not admitted 
through the ED and three cases that developed NF in the 
post-operative period while inpatient. NF was “confirmed” 
by chart review in 167 cases, with 100% interrater agreement 
(Kappa=1.0), but only 80 of these patients had a CRP 
documented in the first 48 hours of presentation. The interrater 
reliability for a positive LRINEC score was excellent 
(Kappa=0.91), as was that for history of diabetes (K=0.84). 
Interrater reliability for history of cirrhosis and intravenous 
drug use was good (K=0.78 for both). Demographic 
characteristics and percentage of cases with each LRINEC 
score are shown in Table.
In the final study cohort, the overall sensitivity of 
the LRINEC score was 77% (CI [66-85]). Patients with 
diabetes were more correctly categorized by the score than 
patients without diabetes (85% vs 67%, p=0.04). There was 
no difference in the score’s sensitivity when patients were 
stratified by age, gender, inpatient mortality nor history of 
cirrhosis or intravenous drug use.
Secondary Analyses
If the CRP and resultant LRINEC score are assumed 
to be “positive” in 50%, 77% or 100% of cases missing 
data, the sensitivity would be 63% (CI [55-70]), 76% (CI 
[69-82]) or 89% (CI [83-93]), respectively. Our analysis of 
missing data gives a range of sensitivities of as low as 55% 
to as high as 93%. 
DISCUSSION
In our population of ED patients with NF, the LRINEC 
score had a measured sensitivity of 77%, substantially 
lower than the 91% reported by Wong.3 Our population 
differs from the Wong cohort in that our patients came 
exclusively from the ED and were younger, more 
frequently male and had a higher mortality rate. Our 
finding that the LRINEC score, applied in isolation, would 
miss over 20% of cases of NF is consistent with reports of 
sensitivities between 68% and 80% in smaller studies based 
in surgical referral centers.6-8,10 
While our sensitivity analyses, based on realistic 
possibilities regarding missing CRP data, suggest that 
the sensitivity of the LRINEC score could range between 
55% and 93%, it is likely that the true value is less than 
80%. Our calculated sensitivity for LRINEC may be 
artificially high, since in clinical practice this score is often 
used to decide whether a patient needs further work up 
or surgical management. Patients with NF and a falsely 
negative LRINEC score are less likely to have the diagnosis 
confirmed through pathologic specimens (and would be 
missed by our study methodology). 
LIMITATIONS
The focus of this study is the sensitivity of the LRINEC 
score in ED patients of one hospital; the findings may have 
limited generalizability. The use of a single ICD-9 code 
may miss cases of NF due to miscoding. The validity of any 
chart review is threatened to the extent that it relies on data 
that is frequently missing, internally inconsistent, and/or 
poorly gathered. To minimize this, we employed standard 
retrospective chart review methodology. Reviewers were 
trained and were largely blinded to our study hypothesis 
and outcome data. We conducted duplicate review to assess 
reliability, used precise definition of both independent and 
dependent variables, and relied on only initial laboratory 
data to decrease inconsistency. We minimized issues 
with missing data, except with regard to CRP. To address 
the high number of missing CRP values, we performed 
sensitivity analyses covering reasonable assumptions about 
how the missing values might have affected our results. 
As no possible values for the missing data could have 
produced a high sensitivity of the LRINEC, our primary 
conclusion – that a normal LRINEC score should not 
by itself be used to rule out NF – remains qualitatively 
unchallenged regardless of what these missing CRP values 
might have been. Additionally, it is possible that spectrum 
bias is present, and that the LRINEC score performs better 
in the most severe cases; however, an ideal diagnostic 
adjunct would aid a clinician in identifying the correct 
diagnosis in subtle cases. 
CONCLUSION
In this cohort, the LRINEC score with the standard 
cut-off of six would miss over 20% of cases of NF. Our 
results suggest that clinicians must maintain a high index of 
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suspicion, and avoid the trap of using a “normal” LRINEC 
score, in isolation, to dismiss the diagnosis. While a lower cut-
off might improve the sensitivity, the accompanying cost to 
specificity is not knowable in this study.
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